ML17166A394: Difference between revisions
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
||
Line 18: | Line 18: | ||
=Text= | =Text= | ||
{{#Wiki_filter:June 9, 2017 Secretary U.S. Nuclear Regulatory Commission ATTN: Rulemakings and Adjudications Staff Washington | {{#Wiki_filter:June 9, 2017 Secretary U.S. Nuclear Regulatory Commission ATTN: Rulemakings and Adjudications Staff Washington , DC 20555-0001 SMT-2017-025 | ||
, DC 20555-0001 SMT-2017-025 | |||
==References:== | ==References:== | ||
(1) U.S. Nuclear Regulatory Commission, "Non-Power Production or Utilization Facility License Renewal (1 O CFR Parts 2, 50, and 51 )," Federal Register, Vol. 82, No. 60, March 30, 2017, pp. 15643-15660 SHINE Medical Technologies. | (1) U.S. Nuclear Regulatory Commission, " Non-Power Production or Utilization Facility License Renewal (1 O CFR Parts 2, 50 , and 51 )," Federal Register , Vol. 82 , No. 60 , March 30 , 2017 , pp. 15643-15660 SHINE Medical Technologies. | ||
Inc. Comments on Proposed Rulemaking Related to Non-Power Production or Utilization Facility License Renewal (Docket ID NRC-2011-0087) | Inc. Comments on Proposed Rulemaking Related to Non-Power Production or Utilization Facility License Renewal (Docket ID NRC-2011-0087) | ||
SHINE Medical Technolog | SHINE Medical Technolog i es , Inc. (SHINE) appreciates the opportunity to comment on the proposed rulemaking related to non-power production or utilization facility license renewal (Reference 1 ). Enclosure 1 provides the SHINE comments on Reference (1 ). If you have any questions , please contact me at 608/210-1735. Very truly yours , Jeff Bartelme Licensing Manager SHINE Medical Technologies , Inc. Docket No. 50-608 Enclosure cc: Steven T. Lynch , Project Manager , USNRC 101 E. Milwaukee Street , Suite 600 I Janesville , WI 53545 IP (608) 210-1060 IF (608) 210-2504 I www.sh i nemed.com ENCLOSURE 1 SHINE MEDICAL TECHNOLOGIES, INC. SHINE MEDICAL TECHNOLOGIES, INC. COMMENTS ON PROPOSED RULEMAKING RELATED TO NON-POWER PRODUCTION OR UTILIZATION FACILITY LICENSE RENEWAL (DOCKET ID NRC-2011-0087) | ||
, please contact me at 608/210-1735. Very truly yours, Jeff Bartelme Licensing Manager SHINE Medical Technologies | The proposed rulemaking related to non-power production or utilization facility license renewal (Reference 1 ), in part, amends 1 O CFR 50.2 to include a definition for "non-power production or utilization facility," of "NPUF." As described in Reference (1 ), the creation of a definition for NPUF is intended to address inconsistencies in definitions and terminology associated with NPUFs, which result in challenges in determining the applicability of certain regulations. | ||
, Inc. Docket No. 50-608 Enclosure cc: Steven T. Lynch, Project Manager, USNRC 101 E. Milwaukee Street, Suite 600 I Janesville | The existing definitions for non-power facilities do not include new entities like SHINE Medical Technologies , Inc. (SHINE). Although the proposed rule is intended to ensure clarity and consistency in the applicability of the associated regulations for NPUFs, the scope of the proposed rulemaking leaves uncertainty in the applicability of certain regulations within Title 1 O of the Code of Federal Regulations to SHINE and other future entities. | ||
, WI 53545 IP (608) 210-1060 IF (608) 210-2504 I www. | Reactor-specific regulations are not applicable to SHINE, despite the classification of the SHINE facility as an NPUF along with non-power reactors, research reactors, and testing facilities. | ||
The proposed rulemaking related to non-power production or utilization facility license renewal (Reference 1 ), in part, amends 1 O CFR 50.2 to include a definition for "non-power production or utilization facility," | |||
of "NPUF." As described in Reference (1 ), the creation of a definition for NPUF is intended to address inconsistencies in definitions and terminology associated with NPUFs, which result in challenges in determining the applicability of certain regulations. | |||
The existing definitions for non-power facilities do not include new entities like SHINE Medical Technologies | |||
, Inc. (SHINE). Although the proposed rule is intended to ensure clarity and consistency in the applicability of the associated regulations for NPUFs, the scope of the proposed rulemaking leaves uncertainty in the applicability of certain regulations within Title 1 O of the Code of Federal Regulations to SHINE and other future entities. | |||
Reactor-specific regulations are not applicable to SHINE, despite the classification of the SHINE facility as an NPUF along with non-power | |||
Specific examples of such regulations, applicable to certain NPUFs but not applicable to SHINE, are provided below. This is not intended to be an all-inclusive listing. | Specific examples of such regulations, applicable to certain NPUFs but not applicable to SHINE, are provided below. This is not intended to be an all-inclusive listing. | ||
* 1 O CFR 171.15, "Annual fees: Reactor licenses and independent spent fuel storage licenses. | * 1 O CFR 171.15, "Annual fees: Reactor licenses and independent spent fuel storage licenses." 10 CFR 171.15(f) provides the annual fees for licensees authorized to operate a non-power reactor licensed under 1 O CFR Part 50. Annual fees applicable to each a research reactor and a test reactor are provided in 1 O CFR 171.15(f); | ||
" 10 CFR 171.15(f) provides the annual fees for licensees authorized to operate a non-power reactor licensed under 1 O CFR Part 50. Annual fees applicable to each a research reactor and a test reactor are provided in 1 O CFR 171.15(f); | however, the subject annual fees are not applicable to the SHINE facility. | ||
* 10 CFR 140.11, ''Amounts of financial protection for certain reactors." The SHINE Construction Permit (Reference | |||
* 10 CFR 140.11, ''Amounts of financial protection for certain reactors." | : 2) is conditioned such that the Commission will not issue a license authorizing operation of the SHINE facility unless SHINE executes an indemnity agreement as required by Section 170 of the Atomic Energy Action of 1954, as amended (the Act). 1 O CFR 140.11 provides the amount of financial protection required of licensees to satisfy the requirements of the indemnification agreement, based on the nuclear reactor's thermal power level. As the requirements of 1 O CFR 140.11 are reactor-specific, they are not applicable to SHINE. The financial protection requirements provided in 1 O CFR 140.12, ''Amount of financial protection required for other reactors.," intended to cover facilities for which the amount of financial protection is not determined in 10 CFR 140.11, is also written as reactor-specific, and not applicable to SHINE. SHINE recommends expanding the scope of the proposed rulemaking to provide clarity and consistency in the applicability of associated regulations for NPUFs within the entirety of Title 10 , Chapter I, of the Code of Federal Regulations. | ||
The SHINE Construction Permit (Reference | Page 1 of 2 References (1) U.S. Nuclear Regulatory Commission , "Non-Power Production or Utilization Facility License Renewal (10 CFR Parts 2, 50, and 51 )," Federal Register , Vol. 82 , No. 60 , March 30 , 2017 , pp. 15643-15660 (2) NRC letter to SHINE Medical Technologies , Inc., " SHINE Medical Technologies , Inc. -Issuance of Construction Permit for Medical Isotope Facility ," dated February 26 , 2016 (ML 16041 A473) Page 2 of 2}} | ||
: 2) is conditioned such that the Commission will not issue a license authorizing operation of the SHINE facility unless SHINE executes an indemnity agreement as required by Section 170 of the Atomic Energy Action of 1954, as amended (the Act). 1 O CFR 140.11 provides the amount of financial protection required of licensees to satisfy the requirements of the indemnification agreement, based on the nuclear reactor's thermal power level. As the requirements of 1 O CFR 140.11 are reactor-specific, they are not applicable to SHINE. The financial protection requirements provided in 1 O CFR 140.12, ''Amount of financial protection required for other reactors., | |||
" intended to cover facilities for which the amount of financial protection is not determined in 10 CFR 140.11, is also written as reactor-specific, and not applicable to SHINE. SHINE recommends expanding the scope of the proposed rulemaking to provide clarity and consistency in the applicability of associated regulations for NPUFs within the entirety of Title 10, Chapter I, of the Code of Federal Regulations. | |||
Page 1 of 2 References (1) U.S. Nuclear Regulatory Commission | |||
, "Non-Power Production or Utilization Facility License Renewal (10 CFR Parts 2, 50, and 51 )," Federal Register, Vol. 82, No. 60, March 30, 2017, pp. 15643-15660 (2) NRC letter to SHINE Medical Technologies | |||
, Inc., "SHINE Medical Technologies | |||
, Inc. -Issuance of Construction Permit for Medical Isotope Facility," dated February 26, 2016 (ML 16041 A473) Page 2 of 2}} |
Latest revision as of 20:36, 7 July 2018
ML17166A394 | |
Person / Time | |
---|---|
Site: | SHINE Medical Technologies |
Issue date: | 06/09/2017 |
From: | Bartelme J SHINE Medical Technologies |
To: | Vietti-Cook A L NRC/SECY/RAS |
SECY/RAS | |
References | |
82FR15643 00009, NRC-2011-0087, SMT-2017-025 | |
Download: ML17166A394 (3) | |
Text
June 9, 2017 Secretary U.S. Nuclear Regulatory Commission ATTN: Rulemakings and Adjudications Staff Washington , DC 20555-0001 SMT-2017-025
References:
(1) U.S. Nuclear Regulatory Commission, " Non-Power Production or Utilization Facility License Renewal (1 O CFR Parts 2, 50 , and 51 )," Federal Register , Vol. 82 , No. 60 , March 30 , 2017 , pp. 15643-15660 SHINE Medical Technologies.
Inc. Comments on Proposed Rulemaking Related to Non-Power Production or Utilization Facility License Renewal (Docket ID NRC-2011-0087)
SHINE Medical Technolog i es , Inc. (SHINE) appreciates the opportunity to comment on the proposed rulemaking related to non-power production or utilization facility license renewal (Reference 1 ). Enclosure 1 provides the SHINE comments on Reference (1 ). If you have any questions , please contact me at 608/210-1735. Very truly yours , Jeff Bartelme Licensing Manager SHINE Medical Technologies , Inc. Docket No. 50-608 Enclosure cc: Steven T. Lynch , Project Manager , USNRC 101 E. Milwaukee Street , Suite 600 I Janesville , WI 53545 IP (608) 210-1060 IF (608) 210-2504 I www.sh i nemed.com ENCLOSURE 1 SHINE MEDICAL TECHNOLOGIES, INC. SHINE MEDICAL TECHNOLOGIES, INC. COMMENTS ON PROPOSED RULEMAKING RELATED TO NON-POWER PRODUCTION OR UTILIZATION FACILITY LICENSE RENEWAL (DOCKET ID NRC-2011-0087)
The proposed rulemaking related to non-power production or utilization facility license renewal (Reference 1 ), in part, amends 1 O CFR 50.2 to include a definition for "non-power production or utilization facility," of "NPUF." As described in Reference (1 ), the creation of a definition for NPUF is intended to address inconsistencies in definitions and terminology associated with NPUFs, which result in challenges in determining the applicability of certain regulations.
The existing definitions for non-power facilities do not include new entities like SHINE Medical Technologies , Inc. (SHINE). Although the proposed rule is intended to ensure clarity and consistency in the applicability of the associated regulations for NPUFs, the scope of the proposed rulemaking leaves uncertainty in the applicability of certain regulations within Title 1 O of the Code of Federal Regulations to SHINE and other future entities.
Reactor-specific regulations are not applicable to SHINE, despite the classification of the SHINE facility as an NPUF along with non-power reactors, research reactors, and testing facilities.
Specific examples of such regulations, applicable to certain NPUFs but not applicable to SHINE, are provided below. This is not intended to be an all-inclusive listing.
- 1 O CFR 171.15, "Annual fees: Reactor licenses and independent spent fuel storage licenses." 10 CFR 171.15(f) provides the annual fees for licensees authorized to operate a non-power reactor licensed under 1 O CFR Part 50. Annual fees applicable to each a research reactor and a test reactor are provided in 1 O CFR 171.15(f);
however, the subject annual fees are not applicable to the SHINE facility.
- 10 CFR 140.11, Amounts of financial protection for certain reactors." The SHINE Construction Permit (Reference
- 2) is conditioned such that the Commission will not issue a license authorizing operation of the SHINE facility unless SHINE executes an indemnity agreement as required by Section 170 of the Atomic Energy Action of 1954, as amended (the Act). 1 O CFR 140.11 provides the amount of financial protection required of licensees to satisfy the requirements of the indemnification agreement, based on the nuclear reactor's thermal power level. As the requirements of 1 O CFR 140.11 are reactor-specific, they are not applicable to SHINE. The financial protection requirements provided in 1 O CFR 140.12, Amount of financial protection required for other reactors.," intended to cover facilities for which the amount of financial protection is not determined in 10 CFR 140.11, is also written as reactor-specific, and not applicable to SHINE. SHINE recommends expanding the scope of the proposed rulemaking to provide clarity and consistency in the applicability of associated regulations for NPUFs within the entirety of Title 10 , Chapter I, of the Code of Federal Regulations.
Page 1 of 2 References (1) U.S. Nuclear Regulatory Commission , "Non-Power Production or Utilization Facility License Renewal (10 CFR Parts 2, 50, and 51 )," Federal Register , Vol. 82 , No. 60 , March 30 , 2017 , pp. 15643-15660 (2) NRC letter to SHINE Medical Technologies , Inc., " SHINE Medical Technologies , Inc. -Issuance of Construction Permit for Medical Isotope Facility ," dated February 26 , 2016 (ML 16041 A473) Page 2 of 2